# Prometheus Biosciences Inc. (RXDX)

Source: https://www.quantisnow.com/company/RXDX
Generated: 2026-11-14T06:11:21.592Z

- Ticker: RXDX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2021
- Website: prometheusbiosciences.com

## About

Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of precision therapeutics and companion diagnostics products for the treatment and diagnosis of inflammatory bowel diseases (IBD). Its products include PRA023, a Phase I clinical trial IgG1 humanized monoclonal antibody (mAb); PR600, an anti- tumor necrosis factor mAb for IBD; PR300, a G-protein coupled receptor modulator small molecule for IBD; PR1800, anti-chemokine mAb for IBD; and PR2100, an anti-inflammatory cytokine mAb for IBD. The company has a diagnostics development and collaboration agreement with Takeda Pharmaceutical Company Limited; co-development and manufacturing agreement with Dr. Falk Pharma GmbH; license agreement with Cedars-Sinai Medical Center; and strategic collaboration with Millennium Pharmaceuticals, Inc. Prometheus Biosciences, Inc. was formerly known as Precision IBD, Inc. and changed its name to Prometheus Biosciences, Inc. in October 2019. The company was founded in 2016 and is based in San Diego, California.

## Latest RXDX news and filings

- 2024-10-24 12:00 UTC [Leadership Update] [Cellino Appoints Chris Gibson to Board of Directors](https://www.quantisnow.com/insight/cellino-appoints-chris-gibson-to-board-of-directors-5736326)
- 2023-06-27 19:06 UTC [SEC Form 15-12G filed by Prometheus Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-prometheus-biosciences-inc-4691162)
- 2023-06-16 20:04 UTC [Merck Completes Acquisition of Prometheus Biosciences, Inc.](https://www.quantisnow.com/insight/merck-completes-acquisition-of-prometheus-biosciences-inc-4653050)
- 2023-06-16 20:00 UTC [SEC Form 4] [SEC Form 4 filed by Mckenna Mark C.](https://www.quantisnow.com/insight/sec-form-4-filed-by-mckenna-mark-c-4652998)
- 2023-06-16 20:00 UTC [SEC Form 4] [SEC Form 4 filed by Stenhouse Mark](https://www.quantisnow.com/insight/sec-form-4-filed-by-stenhouse-mark-4652996)
- 2023-06-16 20:00 UTC [SEC Form 4] [SEC Form 4 filed by Hendrix Martin](https://www.quantisnow.com/insight/sec-form-4-filed-by-hendrix-martin-4652994)
- 2023-06-16 20:00 UTC [SEC Form 4] [SEC Form 4 filed by Laur James](https://www.quantisnow.com/insight/sec-form-4-filed-by-laur-james-4652991)
- 2023-06-16 20:00 UTC [SEC Form 4] [SEC Form 4 filed by Papa Joseph C](https://www.quantisnow.com/insight/sec-form-4-filed-by-papa-joseph-c-4652988)
- 2023-06-16 20:00 UTC [SEC Form 4] [SEC Form 4 filed by Swain Judith L](https://www.quantisnow.com/insight/sec-form-4-filed-by-swain-judith-l-4652987)
- 2023-06-16 20:00 UTC [SEC Form 4] [SEC Form 4 filed by Szela Mary T](https://www.quantisnow.com/insight/sec-form-4-filed-by-szela-mary-t-4652983)
- 2023-06-16 20:00 UTC [SEC Form 4] [SEC Form 4 filed by Marshall Keith W](https://www.quantisnow.com/insight/sec-form-4-filed-by-marshall-keith-w-4652979)
- 2023-06-16 20:00 UTC [SEC Form 4] [SEC Form 4 filed by Hassan Fred](https://www.quantisnow.com/insight/sec-form-4-filed-by-hassan-fred-4652978)
- 2023-06-16 20:00 UTC [SEC Form 4] [SEC Form 4 filed by Adams Helen C.](https://www.quantisnow.com/insight/sec-form-4-filed-by-adams-helen-c-4652975)
- 2023-06-16 13:13 UTC [SEC Form 25-NSE filed by Prometheus Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-prometheus-biosciences-inc-4651207)
- 2023-06-16 13:12 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Prometheus Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-prometheus-biosciences-inc-4651205)
- 2023-06-16 13:10 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Prometheus Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-prometheus-biosciences-inc-4651193)
- 2023-06-16 13:07 UTC [SEC Form POSASR filed by Prometheus Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-posasr-filed-by-prometheus-biosciences-inc-4651166)
- 2023-06-16 12:52 UTC [SEC Form 8-K] [Prometheus Biosciences Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/prometheus-biosciences-inc-filed-sec-form-8-k-completion-of-acquisition-4651013)
- 2023-06-15 20:08 UTC [SEC Form 8-K] [Prometheus Biosciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/prometheus-biosciences-inc-filed-sec-form-8-k-submission-of-matters-4648095)
- 2023-06-06 10:04 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Prometheus Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-prometheus-biosciences-inc-4605638)
- 2023-06-02 23:13 UTC [SEC Form 4] [SEC Form 4 filed by Mckenna Mark C.](https://www.quantisnow.com/insight/sec-form-4-filed-by-mckenna-mark-c-4598680)
- 2023-06-02 23:03 UTC [SEC Form 4] [SEC Form 4 filed by Marshall Keith W](https://www.quantisnow.com/insight/sec-form-4-filed-by-marshall-keith-w-4598645)
- 2023-06-02 22:57 UTC [SEC Form 4] [SEC Form 4 filed by Stenhouse Mark](https://www.quantisnow.com/insight/sec-form-4-filed-by-stenhouse-mark-4598603)
- 2023-06-02 22:43 UTC [SEC Form 4] [SEC Form 4 filed by Papa Joseph C](https://www.quantisnow.com/insight/sec-form-4-filed-by-papa-joseph-c-4598582)
- 2023-05-23 10:08 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Prometheus Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-prometheus-biosciences-inc-4542530)
- 2023-05-23 10:06 UTC [SEC Form 8-K] [Prometheus Biosciences Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/prometheus-biosciences-inc-filed-sec-form-8-k-other-events-4542518)
- 2023-05-19 21:47 UTC [SEC Form 4] [SEC Form 4 filed by Szela Mary T](https://www.quantisnow.com/insight/sec-form-4-filed-by-szela-mary-t-4534980)
- 2023-05-19 21:45 UTC [SEC Form 4] [SEC Form 4 filed by Swain Judith L](https://www.quantisnow.com/insight/sec-form-4-filed-by-swain-judith-l-4534978)
- 2023-05-19 21:44 UTC [SEC Form 4] [SEC Form 4 filed by Papa Joseph C](https://www.quantisnow.com/insight/sec-form-4-filed-by-papa-joseph-c-4534972)
- 2023-05-19 21:42 UTC [SEC Form 4] [SEC Form 4 filed by Laur James](https://www.quantisnow.com/insight/sec-form-4-filed-by-laur-james-4534967)
- 2023-05-19 21:41 UTC [SEC Form 4] [SEC Form 4 filed by Hendrix Martin](https://www.quantisnow.com/insight/sec-form-4-filed-by-hendrix-martin-4534962)
- 2023-05-19 21:39 UTC [SEC Form 4] [SEC Form 4 filed by Hassan Fred](https://www.quantisnow.com/insight/sec-form-4-filed-by-hassan-fred-4534954)
- 2023-05-19 21:38 UTC [SEC Form 4] [SEC Form 4 filed by Adams Helen C.](https://www.quantisnow.com/insight/sec-form-4-filed-by-adams-helen-c-4534949)
- 2023-05-16 20:01 UTC [SEC Form DEFM14A] [SEC Form DEFM14A filed by Prometheus Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-defm14a-filed-by-prometheus-biosciences-inc-4514594)
- 2023-05-16 18:37 UTC [Market Insight] [FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A](https://www.quantisnow.com/insight/ftc-files-lawsuit-to-stop-amgen-buying-horizon-therapeutics-sending-4514101)
- 2023-05-10 15:34 UTC [Market Insight] [RBC Capital Maintains Sector Perform on Prometheus Biosciences, Maintains $200 Price Target](https://www.quantisnow.com/insight/rbc-capital-maintains-sector-perform-on-prometheus-biosciences-maintains-200-4478353)
- 2023-05-10 15:00 UTC [Market Insight] [Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023](https://www.quantisnow.com/insight/benzingas-top-ratings-upgrades-downgrades-for-may-10-2023-4478057)
- 2023-05-10 10:31 UTC [Analyst Downgrade] [Prometheus Biosciences downgraded by Jefferies with a new price target](https://www.quantisnow.com/insight/prometheus-biosciences-downgraded-by-jefferies-with-a-new-price-target-4475054)
- 2023-05-10 09:56 UTC [Market Insight] [Jefferies Downgrades Prometheus Biosciences to Hold, Raises Price Target to $200](https://www.quantisnow.com/insight/jefferies-downgrades-prometheus-biosciences-to-hold-raises-price-target-to-4474649)
- 2023-05-09 20:34 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Prometheus Biosciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-prometheus-biosciences-inc-4472586)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/RXDX
- Earnings history: https://www.quantisnow.com/earnings/RXDX
- Dividend history: https://www.quantisnow.com/dividends/RXDX
- Insider transactions: https://www.quantisnow.com/insiders/RXDX
- Options chain: https://www.quantisnow.com/options/RXDX
- SEC 8-K filings only: https://www.quantisnow.com/company/RXDX/8-k
- RSS and alerts for RXDX: https://www.quantisnow.com/docs/rss-feeds.md